Buy Rating on BioRestorative Therapies for Innovative Obesity Treatment Approach

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on BioRestorative Therapies (BRTX – Research Report). The associated price target remains the same with $6.00.

Michael Okunewitch has given his Buy rating due to a combination of factors surrounding BioRestorative Therapies’ innovative approach to obesity treatment. The company’s development of an exosome-based biologic program leverages its ThermoStem brown fat cell platform. This novel strategy targets obesity by focusing on metabolism rather than satiety, complementing existing obesity drugs and potentially allowing for lower dosing while minimizing side effects such as muscle mass loss and negative cardiovascular impacts. The obesity market’s recent expansion in terms of valuation further reinforces the potential for BioRestorative Therapies as its ThermoStem program advances.

Additionally, the differentiated mechanism of action through the use of brown fat cell-derived exosomes positions the program to be potentially orthogonal and synergistic with current treatments. The preclinical data has shown promise with the use of brown adipose-derived stem cells on a 3D scaffold, suggesting a viable in vivo application. Okunewitch’s optimism is bolstered by the anticipated regulatory milestones, including the submission of a drug master file and the initiation of first-in-human studies by the end of 2024. These developments indicate a clear path forward for BioRestorative Therapies, contributing to the analyst’s positive outlook on the company’s stock.

BRTX’s price has also changed moderately for the past six months – from $1.890 to $1.420, which is a -24.87% drop .

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.

BioRestorative Therapies (BRTX) Company Description:

Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. The ThermoStem Program focuses on treatments for metabolic disorders and obesity and uses brown fat stem cells, which initial research indicates increased caloric burning and reduced glucose and lipid levels in the body. It also offers plant stem cell-based facial creams and products under the Stem Pearls brand. Biorestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.